-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation
-
Pharmacological treatment of endometriosis: update from recent clinical trials
Simone Ferrero, Valentino ,Remorgida, Pier Luigi Venturini
Review Article: Clinical Investigation